Early engraftment of G-CSF-primed allogeneic bone marrow transplantation in pediatric patients regardless of donor-recipient weight differences

Annals of Hematology

Volumn 91, Issue 5, 2012, Pages 751-758

  Kim, Hyery ^a   Kang, Hyoung Jin ^a   Lee, Ji Won ^a   Park, Kyung Duk ^a   Shin, Hee Young ^a   Ahn, Hyo Seop ^a  

^a Seoul National University College of Medicine   (South Korea)

Author keywords

Allogeneic bone marrow transplantation; Engraftment; Granulocyte colony stimulating factor; Growth factor primed bone marrow

Indexed keywords

ACICLOVIR; BUSULFAN; CIPROFLOXACIN; COTRIMOXAZOLE; CYCLOPHOSPHAMIDE; CYCLOSPORIN; ETOPOSIDE; FLUDARABINE; ISONIAZID; ITRACONAZOLE; METHYLPREDNISOLONE; PREDNISOLONE; PROCARBAZINE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; STEROID; THYMOCYTE ANTIBODY; GRANULOCYTE COLONY STIMULATING FACTOR;

ACUTE GRAFT VERSUS HOST DISEASE; ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; ALLOGENIC BONE MARROW TRANSPLANTATION; APLASTIC ANEMIA; ARTICLE; BODY WEIGHT; CHILD; CHRONIC GRAFT VERSUS HOST DISEASE; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; CONTINUOUS INFUSION; CONTROLLED STUDY; DONOR; DRUG DOSE TITRATION; ENZYME RECONSTITUTION; FEMALE; GRAFT RECIPIENT; GRAFT VERSUS HOST REACTION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFECTION; INFECTION PREVENTION; LEUKEMIA; MALE; MEDICAL RECORD REVIEW; MYELODYSPLASTIC SYNDROME; MYELOID METAPLASIA; NEUTROPHIL COUNT; PRESCHOOL CHILD; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCHOOL CHILD; WHOLE BODY RADIATION; ALLOTRANSPLANTATION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HISTOCOMPATIBILITY; IMMUNOLOGY; LYMPHOCYTE COUNT; LYMPHOCYTE SUBPOPULATION; METHODOLOGY; STEM CELL MOBILIZATION; SURVIVAL RATE;

ADOLESCENT; ADULT; BODY WEIGHT; CHILD; CHILD, PRESCHOOL; FEMALE; GRAFT VS HOST DISEASE; GRANULOCYTE COLONY-STIMULATING FACTOR; HEMATOPOIETIC STEM CELL MOBILIZATION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; LYMPHOCYTE COUNT; LYMPHOCYTE SUBSETS; MALE; SURVIVAL RATE; TISSUE DONORS; TRANSPLANTATION CHIMERA; TRANSPLANTATION, HOMOLOGOUS; YOUNG ADULT;

EID: 84861431904     PISSN: 09395555     EISSN: 14320584     Source Type: Journal    
DOI: 10.1007/s00277-011-1360-7     Document Type: Article

References (23)

1. Cutler C, Giri S, Jeyapalan S, Paniagua D, Viswanathan A, Antin JH (2001) Acute and chronic graft-versus-host disease after allogeneic peripheral-blood stem-cell and bone marrow transplantation: a meta-analysis. J Clin Oncol 19:3685-3691 (Pubitemid 32786281)
2. Storek J, Gooley T, Siadak M, Bensinger WI, Maloney DG, Chauncey TR, Flowers M, Sullivan KM, Witherspoon RP, Rowley SD, Hansen JA, Storb R, Appelbaum FR (1997) Allogeneic peripheral blood stem cell transplantation may be associated with a high risk of chronic graft-versus-host disease. Blood 90:4705-4709 (Pubitemid 28007182)
3. Frangoul H, Nemecek ER, Billheimer D, Pulsipher MA, Khan S, Woolfrey A, Manes B, Cole C, Walters MC, Ayas M, Ravindranath Y, Levine JE, Grupp SA (2007) A prospective study of G-CSF primed bone marrow as a stem-cell source for allogeneic bone marrow transplantation in children: a Pediatric Blood and Marrow Transplant Consortium (PBMTC) study. Blood 110:4584-4587 (Pubitemid 351377827)
4. Morton J, Hutchins C, Durrant S (2001) Granulocyte-colonystimulating factor (G-CSF)-primed allogeneic bone marrow: significantly less graft-versus-host disease and comparable engraftment to G-CSF-mobilized peripheral blood stem cells. Blood 98:3186-3191
5. Isola LM, Scigliano E, Skerrett D, Shank B, Ross V, Najfeld V, Fruchtman S (1997) A pilot study of allogeneic bone marrow transplantation using related donors stimulated with G-CSF. Bone Marrow Transplant 20:1033-1037 (Pubitemid 28043414)
6. Grupp SA, Frangoul H, Wall D, Pulsipher MA, Levine JE, Schultz KR (2006) Use of G-CSF in matched sibling donor pediatric allogeneic transplantation: a consensus statement from the Children's Oncology Group (COG) Transplant Discipline Committee and Pediatric Blood and Marrow Transplant Consortium (PBMTC) Executive Committee. Pediatr Blood Cancer 46:414-421 (Pubitemid 43334646)
7. Pulsipher MA, Nagler A, Iannone R, Nelson RM (2006) Weighing the risks of G-CSF administration, leukopheresis, and standard marrow harvest: ethical and safety considerations for normal pediatric hematopoietic cell donors. Pediatr Blood Cancer 46:422-433 (Pubitemid 43334647)
8. Kang HJ, Yoo KH, Jang PS, Choi HS, Shin HY, Ahn HS (2001) Early engraftment of G-CSF primed allogeneic bone marrow transplantation in children. Korean J Hematop Stem Cell Transplant 6:1-7
9. Morrison SJ, Wright DE, Weissman IL (1997) Cyclophosphamide/ granulocyte colony-stimulating factor induces hematopoietic stem cells to proliferate prior to mobilization. Proc Natl Acad Sci U S A 94:1908-1913 (Pubitemid 27113935)
10. Kang HJ, Shin HY, Park JE, Chung NG, Cho B, Kim HK, Kim SY, Lee YH, Lim YT, Yoo KH, Sung KW, Koo HH, Im HJ, Seo JJ, Park SK, Ahn HS (2010) Successful engraftment with fludarabine, cyclophosphamide, and thymoglobulin conditioning regimen in unrelated transplantation for severe aplastic anemia: a phase II prospective multicenter study. Biol Blood Marrow Transplant 16:1582-1588
11. Serody JS, Sparks SD, Lin Y, Capel EJ, Bigelow SH, Kirby SL, Gabriel DA, Wiley JM, Brecher ME, Schell MJ, Folds J, Shea TC (2000) Comparison of granulocyte colony-stimulating factor (GCSF)-mobilized peripheral blood progenitor cells and G-CSF-stimulated bone marrow as a source of stem cells in HLA-matched sibling transplantation. Biol Blood Marrow Transplant 6:434-440
12. Couban S, Simpson DR, Barnett MJ, Bredeson C, Hubesch L, Howson-Jan K, Shore TB, Walker IR, Browett P, Messner HA, Panzarella T, Lipton JH (2002) A randomized multicenter comparison of bone marrow and peripheral blood in recipients of matched sibling allogeneic transplants for myeloid malignancies. Blood 100:1525-1531 (Pubitemid 34925122)
13. Ji SQ, Chen HR, Wang HX, Yan HM, Pan SP, Xun CQ (2002) Comparison of outcome of allogeneic bone marrow transplantation with and without granulocyte colony-stimulating factor (lenograstim) donor-marrow priming in patients with chronic myelogenous leukemia. Biol Blood Marrow Transplant 8:261-267
14. Kernan NA, Collins NH, Juliano L, Cartagena T, Dupont B, O'Reilly RJ (1986) Clonable T lymphocytes in T cell-depleted bone marrow transplants correlate with development of graft-vhost disease. Blood 68:770-773 (Pubitemid 16008184)
15. Singhal S, Powles R, Treleaven J, Kulkarni S, Sirohi B, Horton C, Millar B, Shepherd V, Tait D, Saso R, Rowland A, Long S, Mehta J (2000) A low CD34+ cell dose results in higher mortality and poorer survival after blood or marrow stem cell transplantation from HLA-identical siblings: should 2 x 10(6) CD34+ cells/kg be considered the minimum threshold? Bone Marrow Transplant 26:489-496
16. Bahceci E, Read EJ, Leitman S, Childs R, Dunbar C, Young NS, Barrett AJ (2000) CD34+ cell dose predicts relapse and survival after T-cell-depleted HLA-identical haematopoietic stem cell transplantation (HSCT) for haematological malignancies. Br J Haematol 108:408-414 (Pubitemid 30143660)
17. Mavroudis D, Read E, Cottler-Fox M, Couriel D, Molldrem J, Carter C, Yu M, Dunbar C, Barrett J (1996) CD34+ cell dose predicts survival, posttransplant morbidity, and rate of hematologic recovery after allogeneic marrow transplants for hematologic malignancies. Blood 88:3223-3229 (Pubitemid 26357408)
18. Grigg AP, Roberts AW, Raunow H, Houghton S, Layton JE, Boyd AW, McGrath KM, Maher D (1995) Optimizing dose and scheduling of filgrastim (granulocyte colony-stimulating factor) for mobilization and collection of peripheral blood progenitor cells in normal volunteers. Blood 86:4437-4445
19. Mandalam RKVC, Stiff PJ, Broyy DA, Smith AK (1997) Stem and progenitor cell content and ex vivo expansion potential of human bone marrow primed in vivo with G-CSF. Blood 90(suppl 2):344b
20. Martinez C, Urbano-Ispizua A, Rozman M, Rovira M, Marin P, Montfort N, Carreras E, Montserrat E (1999) Effects of short-term administration of G-CSF (filgrastim) on bone marrow progenitor cells: analysis of serial marrow samples from normal donors. Bone Marrow Transplant 23:15-19 (Pubitemid 29050173)
21. Min CK, Kim DW, Lee JW, Han CW, Min WS, Kim CC (2001) Hematopoietic stem cell transplantation for high-risk adult patients with severe aplastic anemia; reduction of graft failure by enhancing stem cell dose. Haematologica 86:303-310
22. Armand P, Antin JH (2007) Allogeneic stem cell transplantation for aplastic anemia. Biol Blood Marrow Transplant 13:505-516 (Pubitemid 46585938)
23. Schrezenmeier H, Passweg JR, Marsh JC, Bacigalupo A, Bredeson CN, Bullorsky E, Camitta BM, Champlin RE, Gale RP, Fuhrer M, Klein JP, Locasciulli A, Oneto R, Schattenberg AV, Socie G, Eapen M (2007) Worse outcome and more chronic GVHD with peripheral blood progenitor cells than bone marrow in HLA-matched sibling donor transplants for young patients with severe acquired aplastic anemia. Blood 110:1397-1400 (Pubitemid 47281442)